SCHEDULE 13G: First Trust Entities Disclose 6.33% Stake in abrdn Life Sciences Investors

First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly disclosed a 6.33% beneficial ownership stake in abrdn Life Sciences Investors, totaling 1,827,112 common shares.

Summary

• First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation have jointly filed a Schedule 13G, disclosing their beneficial ownership in abrdn Life Sciences Investors.
• The aggregate amount beneficially owned by the reporting group is 1,827,112 common shares.
• This ownership represents 6.33% of the class of abrdn Life Sciences Investors' common stock.
• The shares are primarily held through unit investment trusts sponsored by First Trust Portfolios L.P., and other registered investment companies, pooled investment vehicles, and separately managed accounts for which First Trust Advisors L.P. serves as investment advisor or sub-advisor.
• The reporting persons disclaim beneficial ownership, noting that voting power for the unit investment trusts' shares is generally exercised by the trustee to mirror other shareholders.

Sentiment

Score: 5

Explanation: The document is a factual regulatory disclosure of beneficial ownership, inherently neutral in sentiment. It does not convey positive or negative news about the issuer's performance or outlook.

Future Outlook

The document is a disclosure of current beneficial ownership and does not contain forward-looking statements or guidance regarding future performance or strategic plans of abrdn Life Sciences Investors or the reporting entities.

Management Comments

• "To the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11."
• "Each of First Trust Portfolios L.P., First Trust Advisors L.P. and The Charger Corporation disclaims beneficial ownership of the shares of the issuer identified in this filing."

Industry Context

This filing indicates a significant institutional investment in the life sciences sector, reflecting ongoing interest from investment management firms like First Trust in specialized funds such as abrdn Life Sciences Investors. It highlights the role of large asset managers in holding substantial stakes in publicly traded investment vehicles.

Related Party Transactions

• The Charger Corporation is the General Partner of both First Trust Portfolios L.P. and First Trust Advisors L.P., establishing a related party relationship among the reporting entities for the purpose of this joint filing.

Stakeholder Impact

• Shareholders of abrdn Life Sciences Investors are informed of a significant institutional holder, which can provide stability or influence in voting matters, though the reporting persons disclaim control intent.
• The filing clarifies the structure of ownership for investors in First Trust's unit investment trusts and other managed accounts.

Key Dates

Keywords

abrdn Life Sciences Investors, First Trust Portfolios, First Trust Advisors, The Charger Corporation, Schedule 13G, Beneficial Ownership, Institutional Investor, Investment Management, Common Stock, SEC Filing, Life Sciences